Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04624399 |
| Title | Phase 2 Study of Neoadjuvant Immune Checkpoint Inhibitors in Urothelial Cancer (ABACUS-2) |
| Acronym | ABACUS-2 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Queen Mary University of London |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Barts and London Hospital NHS Trust | RECRUITING | London | United Kingdom | Details |